MedPath

VLX-1005

Generic Name
VLX-1005
Drug Type
Small Molecule
Chemical Formula
C21H19N3O4S2
CAS Number
1532593-30-8
Unique Ingredient Identifier
JKU4XCC48Y

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 2
Recruiting
Posted: 2023/03/27
Sponsor:
Veralox Therapeutics
Phase 1
Completed
Posted: 2021/03/05
Sponsor:
Veralox Therapeutics

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath